MONTGOMERY, Texas--(BUSINESS WIRE)--Endovasc, Inc - (OTCBB:EVSC)
a Business Development Company focused on acquiring and investing in
companies engaged in the development of...
MONTGOMERY, Texas--(BUSINESS WIRE)--Endovasc, Inc. - (OTCBB: EVSC),
a Business Development Company focused on acquiring and investing in
companies engaged in the development of...
MONTGOMERY, Texas--(BUSINESS WIRE)--Endovasc, Inc. - (OTCBB: EVSC),
a Business Development Company focused on acquiring and investing in
companies engaged in the development of...
MONTGOMERY, Texas--(BUSINESS WIRE)--Endovasc, Inc - (OTCBB: EVSC),
a Business Development Company focused on acquiring and investing in
companies engaged in the development of...
MONTGOMERY, Texas--(BUSINESS WIRE)--Endovasc, Inc - (OTCBB: EVSC)
would like to issue a clarification regarding its previously announced
Annual Meeting of Stockholders on December 21,...
MONTGOMERY, Texas--(BUSINESS WIRE)--Endovasc, Inc. - (OTCBB: EVSC),
a Business Development Company focused on acquiring and investing in
companies engaged in the development of...
MONTGOMERY, Texas--(BUSINESS WIRE)--Endovasc, Inc. (OTCBB: EVSC),
a Business Development Company focused on acquiring and investing in
innovative drug development in the areas of...
HOUSTON--(BUSINESS WIRE)--ENDOVASC INC. (OTCBB:EVSC),
today announced that Analytical Bio-Chemical Laboratories, Inc. (ABC)
has developed a highly sensitive High Performance Liquid ...
HOUSTON--(BUSINESS WIRE)--Sept. 6, 2006--ENDOVASC INC. (OTCBB:EVSC), today announced that PYRAMID Laboratories, Inc. has completed the cGMP manufacturing of Liprostin for the Company's proposed...
HOUSTON--(BUSINESS WIRE)--Aug. 8, 2006--Endovasc Inc. (OTCBB: EVSC, OTC: EVSD), today announced that the United States Patent and Trademark Office has granted the Company a patent entitled...
HOUSTON--(BUSINESS WIRE)--Aug. 1, 2006--Endovasc Inc. (OTCBB: EVSC), announced that Dr. Diane Dottavio, the Company's President and CEO, appeared on the Wall Street Reporter to discuss its planned...
HOUSTON--(BUSINESS WIRE)--July 24, 2006--Endovasc Inc. (OTCBB: EVSC), announced that the Company's President and CEO, Dr. Diane Dottavio, was featured in an exclusive interview with WallSt.net on...
HOUSTON--(BUSINESS WIRE)--July 17, 2006--Endovasc Inc. (OTCBB: EVSC), cites positive market conditions for its leading drug candidate, Liprostin, for the treatment of intermittent claudication, a...
HOUSTON--(BUSINESS WIRE)--July 6, 2006--Endovasc Inc. (OTCBB: EVSC, OTC: EVSD), announced today that the Company has received a patent issue notification from the United States Patent and Trademark...
HOUSTON--(BUSINESS WIRE)--June 27, 2006--ENDOVASC INC. (OTCBB:EVSC), today announced that the Company has awarded ABC Laboratories a contract to develop an assay to determine the content of...